Analyses of hind leg skeletons in human growth hormone transgenic rats.
Growth hormone (GH) is essential in the development and growth of the skeleton and for the maintenance of bone mass and density, and its secretion is known to decline with aging. We have previously produced transgenic rats with low circulating GH that represent several age-associated phenotypes such as obesity, insulin-resistance and leptin-resistance. In the present study, the cross-sectional area, bone mineral density, and strength indexes of the hind leg skeletons of the transgenic rats were examined by an X-ray computed tomography scanning. The mean cross-sectional area of the transgenic rats showed no increase after 2 months old up to 8 months old and the strength indexes were significantly lower than their non-transgenic siblings at all ages examined. The trabecular bone mineral density in the transgenic rats drastically decreased at 8 months old, while the cortical bone mineral density was comparable to the non-transgenic rats, suggesting the onset of osteoporosis at this period. The results obtained in this study indicate that the transgenic rats could be useful model to gain insight into the complex mechanism leading to osteoporosis with aging.
Department of Veterinary Physiology, Veterinary Medical Science, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan. akeita@mail.ecc.u-tokyo.ac.jp
Keitaro
K
Yamanouchi
Erica
E
Yada
Hiroyuki
H
Hozumi
Chiori
C
Ueno
Masugi
M
Nishihara
D000375:Aging; D000818:Animals; D030801:Animals, Genetically Modified; D015519:Bone Density; D001842:Bone and Bones / Q000378:metabolism*; D002118:Calcium / Q000097:blood; D013006:Growth Hormone / Q000097:blood; D006614:Hindlimb; D019382:Human Growth Hormone / Q000235:genetics*; D008297:Male; D023421:Models, Animal; D015675:Osteocalcin / Q000097:blood; D010024:Osteoporosis; D010758:Phosphorus / Q000097:blood; D051381:Rats
D015675:Osteocalcin; D019382:Human Growth Hormone; D010758:Phosphorus; D013006:Growth Hormone; D002118:Calcium